Showing results (231-240 of 313) with videos related to

Sort By:
Pageof 32
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 7, 2025
Impact of pulmonary hypertension on short and long-term outcome after mitral transcatheter edge-to-edge repair: A meta-analysisSivaram Neppala, Himaja Dutt Chigurupati, Ayman Fath, et al.
Diabetes|March 1, 2007
Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response studyApiradee Sriwijitkamol, Dawn K Coletta, Estela Wajcberg, et al.
Diabetes|October 24, 2024
Effect of Hyperketonemia on Myocardial Function in Patients With Heart Failure and Type 2 DiabetesCarolina Solis-Herrera, Yuejuan Qin, Henri Honka, et al.
Diabetes|October 22, 2008
Genome-wide linkage scan for genes influencing plasma triglyceride levels in the Veterans Administration Genetic Epidemiology StudyDawn K Coletta, Jennifer Schneider, Shirley L Hu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 29, 2021
Ultrasound-Targeted Microbubble Destruction Mediates Gene Transfection for Beta-Cell Regeneration and Glucose RegulationChao Zhang, Shuyuan Chen, Qunying Li, et al.
Diabetes Care|April 29, 2006
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative studyDavid M Kendall, Cindy J Rubin, Pharis Mohideen, et al.
Endocrinology|January 7, 2015
Peripheral insulin resistance and impaired insulin signaling contribute to abnormal glucose metabolism in preterm baboonsCynthia L Blanco, Lisa L McGill-Vargas, Amalia Gastaldelli, et al.
Diabetes|August 28, 2012
Disruption of growth factor receptor-binding protein 10 in the pancreas enhances β-cell proliferation and protects mice from streptozotocin-induced β-cell apoptosisJingjing Zhang, Ning Zhang, Meilian Liu, et al.
Diabetes, Obesity & Metabolism|January 11, 2022
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)Olga Lavynenko, Muhammad Abdul-Ghani, Mariam Alatrach, et al.
Diabetes|January 5, 2008
Physiological and molecular determinants of insulin action in the baboonAlberto O Chavez, Juan C Lopez-Alvarenga, M Elizabeth Tejero, et al.
Pageof 32